Officials gird for a war on vaccine misinformation

Science
03 July 2020 Vol 369, Issue 6499
http://www.sciencemag.org/current.dtl

 

In Depth
Officials gird for a war on vaccine misinformation
By Warren Cornwall
Science03 Jul 2020 : 14-15 Full Access
Summary
As scientists rush to develop a vaccine for the new coronavirus, experts warn that public health agencies need new strategies to persuade people to accept a vaccine. Antivaccine activists have helped stoke rising levels of “vaccine hesitancy” in the United States and elsewhere. Now, those groups are turning their attention to the coronavirus. Polls have found as few as half of Americans are committed to taking the coronavirus vaccine. Now, researchers who study health behavior are urging adoption of some of the tactics used by vaccine critics: telling compelling, personal stories; spreading messages quickly and creatively through social media; offering more individualized responses to the concerns of different groups; and recruiting volunteers to act as a pro-vaccine counterweight

 

Improve alignment of research policy and societal values

Science
03 July 2020 Vol 369, Issue 6499
http://www.sciencemag.org/current.dtl

 

Policy Forum
Improve alignment of research policy and societal values
By Peter Novitzky, Michael J. Bernstein, Vincent Blok, Robert Braun, Tung Tung Chan, Wout Lamers, Anne Loeber, Ingeborg Meijer, Ralf Lindner, Erich Griessler
Science03 Jul 2020 : 39-41 Restricted Access
Summary
Historically, scientific and engineering expertise has been key in shaping research and innovation (R&I) policies, with benefits presumed to accrue to society more broadly over time (1). But there is persistent and growing concern about whether and how ethical and societal values are integrated into R&I policies and governance, as we confront public disbelief in science and political suspicion toward evidence-based policy-making (2). Erosion of such a social contract with science limits the ability of democratic societies to deal with challenges presented by new, disruptive technologies, such as synthetic biology, nanotechnology, genetic engineering, automation and robotics, and artificial intelligence. Many policy efforts have emerged in response to such concerns, one prominent example being Europe’s Eighth Framework Programme, Horizon 2020 (H2020), whose focus on “Responsible Research and Innovation” (RRI) provides a case study for the translation of such normative perspectives into concrete policy action and implementation. Our analysis of this H2020 RRI approach suggests a lack of consistent integration of elements such as ethics, open access, open innovation, and public engagement. On the basis of our evaluation, we suggest possible pathways for strengthening efforts to deliver R&I policies that deepen mutually beneficial science and society relationships.

 

Factors limiting data quality in the expanded programme on immunization in low and middle-income countries: A scoping review

Vaccine
Volume 38, Issue 30 Pages 4651-4782 (19 June 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/30

 

Review article Open access
Factors limiting data quality in the expanded programme on immunization in low and middle-income countries: A scoping review
Katherine Harrison, Nargis Rahimi, M. Carolina Danovaro-Holliday
Pages 4652-4663

 

Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands

Vaccine
Volume 38, Issue 30 Pages 4651-4782 (19 June 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/30

 

Research article Open access
Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands
Joost J.M. Simons, Nora Vida, Tjalke A. Westra, Maarten J. Postma

 

Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study

Vaccine
Volume 38, Issue 30 Pages 4651-4782 (19 June 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/30

 

Research article Abstract only
Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study
Si Qin, Jing-Xia Fu, Ming-Zhu Chen, Yan-Ting Meng, … Yang Luo
Pages 4732-4739

 

Early smallpox vaccine manufacturing in the United States: Introduction of the “animal vaccine” in 1870, establishment of “vaccine farms”, and the beginnings of the vaccine industry

Vaccine
Volume 38, Issue 30 Pages 4651-4782 (19 June 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/30

 

History of Vaccinology paper
Research article Open access
Early smallpox vaccine manufacturing in the United States: Introduction of the “animal vaccine” in 1870, establishment of “vaccine farms”, and the beginnings of the vaccine industry
José Esparza, Seth Lederman, Andreas Nitsche, Clarissa R. Damaso
Pages 4773-4779

 

Strategies to Improve Vaccination among At-Risk Adults and the Elderly in Italy

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 4 July 2020)

 

Open Access Article
Strategies to Improve Vaccination among At-Risk Adults and the Elderly in Italy
by Giovanna Elisa Calabrò , Alessia Tognetto , Elettra Carini , Silvia Mancinelli , Laura Sarnari , Vittoria Colamesta , Walter Ricciardi and Chiara de Waure
Vaccines 2020, 8(3), 358; https://doi.org/10.3390/vaccines8030358 (registering DOI) – 04 Jul 2020
Abstract
The World Health Organization (WHO), the United States (US) Centers for Disease Control and Prevention (CDC), the European Center for Disease Control (ECDC), and the immunization guidelines of many countries issue vaccination recommendations for adults and the elderly. However, the uptake of vaccination

 

Strategies to Improve Vaccination among At-Risk Adults and the Elderly in Italy

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 4 July 2020)

 

Open Access Article
Strategies to Improve Vaccination among At-Risk Adults and the Elderly in Italy
by Giovanna Elisa Calabrò , Alessia Tognetto , Elettra Carini , Silvia Mancinelli , Laura Sarnari , Vittoria Colamesta , Walter Ricciardi and Chiara de Waure
Vaccines 2020, 8(3), 358; https://doi.org/10.3390/vaccines8030358 (registering DOI) – 04 Jul 2020
Abstract
The World Health Organization (WHO), the United States (US) Centers for Disease Control and Prevention (CDC), the European Center for Disease Control (ECDC), and the immunization guidelines of many countries issue vaccination recommendations for adults and the elderly. However, the uptake of vaccination

 

HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 4 July 2020)

 

Open Access Review
HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
by Andrea Ciavattini , Luca Giannella , Rosa De Vincenzo , Jacopo Di Giuseppe , Maria Papiccio , Ankica Lukic , Giovanni Delli Carpini , Antonio Perino , Antonio Frega , Francesco Sopracordevole , Maggiorino Barbero and Murat Gultekin
Vaccines 2020, 8(3), 354; https://doi.org/10.3390/vaccines8030354 – 02 Jul 2020

 

Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 4 July 2020
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 4 July 2020
Health
Covaxin: India to hold human trial of coronavirus vaccine in July
30 June 2020

 

The Economist
http://www.economist.com/
Accessed 4 July 2020
Leaders
Jul 4th 2020 edition
The way we live now
Covid-19 is here to stay. People will have to adapt
The world is not experiencing a second wave: it never got over the first

Britain
Jul 2nd 2020 edition
Covid-19 – Oxford University is leading in the vaccine race
Governments are pouring money into a more urgent version of the space race

 

Financial Times
http://www.ft.com/home/uk
Accessed 4 July 2020
[No new, unique, relevant content]

 

Forbes
http://www.forbes.com/
Accessed 4 July 2020
Jul 2, 2020
Fauci: Covid-19 Vaccine Safety And Effectiveness Should Be Known ‘By Early Winter’
Dr. Anthony Fauci said the safety and effectiveness of a vaccine for the coronavirus strain Covid-19 should be known by “early winter” with 200 million doses available for U.S. use by early 2021.
By Bruce Japsen Senior Contributor

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 4 July 2020
[No new, unique, relevant content]

 

Foreign Policy
http://foreignpolicy.com/
Accessed 4 July 2020 | [No new, unique, relevant content]
[No new, unique, relevant content]

 

The Guardian
http://www.guardiannews.com/
[No new, unique, relevant content]

 

New Yorker
http://www.newyorker.com/
Accessed 4 July 2020
[No new, unique, relevant content]

 

New York Times
http://www.nytimes.com/
Accessed 4 July 2020
Asia Pacific
India’s Clinical Research Body Defends Timeline for Coronavirus Vaccine Trials
India’s leading clinical research agency said Saturday its decision to fast-track development of a potential coronavirus vaccine was in line with international standards, after health experts raised concerns about the schedule for clinical trials.
By Reuters July 4, 2020

Americas
Brazil Health Regulator Anvisa Allows Chinese COVID-19 Vaccine Trial
Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China’s Sinovac, according to an official gazette publication.
By Reuters July 4, 2020

Asia Pacific
WHO Sees First Results From COVID Drug Trials Within Two Weeks
The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, its Director General Tedros Adhanom Ghebreyesus said on Friday.
By Reuters July 3, 2020

Asia Pacific
Health Experts Cast Doubt on India’s Timeline for COVID Vaccine
The chief of India’s top clinical research agency said in a leaked letter circulated on Friday it envisaged launching a novel coronavirus vaccine by Aug. 15, prompting scepticism from some health experts who questioned the short timeline.
By Reuters July 3, 2020

U.S.
COVID-19 Vaccines to Enter Late-Stage Trial by End of July, Fauci Says
COVID-19 vaccine candidates will enter late-stage clinical studies by the end of the month, with others beginning in August, September and October, the U.S. government’s top infectious diseases expert said on Thursday.
By Reuters July 3, 2020

U.S.
NIH Director Collins Optimistic on COVID-19 Vaccine by Year End
The U.
By Reuters

 

Washington Post
https://www.washingtonpost.com/
Accessed 4 July 2020
Prospect of a coronavirus vaccine unites anti-vaxxers, conspiracy theorists and hippie moms in
Loveday Morris · Jul 3, 2020

 

Think Tanks et al

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 4 July 2020
[No new relevant content]

Center for Global Development [to 4 July 2020]
http://www.cgdev.org/page/press-center
Accessed 4 July 2020
[No new relevant content]

Chatham House [to 4 July 2020]
https://www.chathamhouse.org/
[No new relevant content]

 

CSIS
https://www.csis.org/
Accessed 4 July 2020
[No new relevant content]

 

Council on Foreign Relations
http://www.cfr.org/
Accessed 4 July 2020
June 30, 2020
Pharmaceuticals and Vaccines
What Is the World Doing to Create a COVID-19 Vaccine?
Backgrounder by Claire Felter

 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 4 July 2020
July 1, 2020 News Release
KFF’s Kaiser Health News (KHN), AP Investigate the State of the Nation’s Public Health Infrastructure as It Confronts the Challenge of the COVID-19 Pandemic
A new investigation from KHN and The Associated Press examines the troubling state of the public health infrastructure the nation is relying on to navigate the health and economic threats presented by the COVID-19 pandemic.